Trends in modes of death in heart failure over the last two decades: less sudden death but cancer deaths on the rise
- PMID: 31359563
- DOI: 10.1002/ejhf.1569
Trends in modes of death in heart failure over the last two decades: less sudden death but cancer deaths on the rise
Abstract
Aims: Better management of heart failure (HF) over the past two decades has improved survival, mainly by reducing the incidence of death due to cardiovascular (CV) causes. Deaths due to non-CV causes, particularly cancer, may be increasing. This study explored the modes of death of consecutive patients who attended a HF clinic over 17 years.
Methods and results: A total of 935 deaths were ascertained from 2002 to 2018 among 1876 patients (mean age 65.8 ± 12.5 years, 75% men, left ventricular ejection fraction < 50%) admitted to our HF clinic. Median follow-up was 4.2 years [1.9-7.8]. Mode of death was curated from patient health records and verified by the Catalan and Spanish health system databases. Trends for every mode of death were assessed by polynomial regression. Two trends were observed: a significant reduction in sudden death (P = 0.03) without changes in HF progression as mode of death (P = 0.26), and a significant increase in non-CV modes of death (P < 0.001). Non-CV deaths accounted for 17.4% of deaths in 2002 and 65.8% of deaths in 2018. A total 138 deaths were due to cancer (37% of non-CV deaths). A significant trend was observed towards a progressive increase in cancer deaths over time (P = 0.002). The main mode of cancer mortality was lung cancer.
Conclusions: The modes of death in HF have shifted over the last two decades. Patients with HF die less due to sudden death and more due to non-CV causes, mainly cancer. Whether HF triggers cancer, or cancer develops in HF survivors, deserves further insight.
Keywords: Cancer; Cardiovascular death; Heart failure; Mortality; Non-cardiovascular death; Sudden death.
© 2019 The Authors. European Journal of Heart Failure © 2019 European Society of Cardiology.
Comment in
-
Dying is not what it used to be! Impact of evolving epidemiology and treatment on mode of death in heart failure.Eur J Heart Fail. 2019 Oct;21(10):1267-1269. doi: 10.1002/ejhf.1587. Epub 2019 Aug 13. Eur J Heart Fail. 2019. PMID: 31410990 Free PMC article. No abstract available.
-
What do patients with heart failure die from? A single assassin or a conspiracy?Eur J Heart Fail. 2020 Jan;22(1):26-28. doi: 10.1002/ejhf.1689. Epub 2019 Dec 21. Eur J Heart Fail. 2020. PMID: 31863684 No abstract available.
References
-
- Zafrir B, Paz H, Wolff R, Salman N, Merhavi D, Lewis BS, Amir O. Mortality rates and modes of death in heart failure patients with reduced versus preserved systolic function. Eur J Intern Med 2011;22:53-56.
-
- Poole-Wilson PA, Uretsky BF, Thygesen K, Cleland JG, Massie BM, Rydén L; Atlas Study Group. Assessment of treatment with lisinopril and survival. Mode of death in heart failure: findings from the ATLAS trial. Heart 2003;89:42-48.
-
- Mehta PA, Dubrey SW, McIntyre HF, Walker DM, Hardman SM, Sutton GC, McDonagh TA, Cowie MR. Mode of death in patients with newly diagnosed heart failure in the general population. Eur J Heart Fail 2008;10:1108-1116.
-
- Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93:1137-1146.
-
- Farmakis D, Stafylas P, Giamouzis G, Maniadakis N, Parissis J. The medical and socioeconomic burden of heart failure: a comparative delineation with cancer. Int J Cardiol 2016;203:279-281.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
